Iodide

Iodide

SCHEMBL17555151

C[N+](C)(Cc1ccc(NC(=O)c2cc3cc(Cl)ccc3[nH]2)cc1)C[C@@H]1CCCO1.[I-]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PYGL P06737 15/20 0.56
NHERF1 O14745 3/20 0.56
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
KDM4E B2RXH2 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CCR2 P41597 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL17555152 1.00 PYGL (0.56) PYGLNHERF1MEN1KMT2ARXFP1
SCHEMBL4461560 0.99 PYGL (0.56) PYGLNHERF1MEN1KMT2ARXFP1
SCHEMBL4461554 0.99 PYGL (0.56) PYGLNHERF1MEN1KMT2ARXFP1
Hydrochloric Acid SCHEMBL2696147 0.98 PYGL (0.56) PYGLNHERF1MEN1KMT2ARXFP1
Hydrochloric Acid SCHEMBL2696148 0.98 PYGL (0.56) PYGLNHERF1MEN1KMT2ARXFP1
Iodide SCHEMBL17555143 0.81 CCR2 (0.68) PYGLNHERF1MEN1KMT2ARXFP1
Iodide SCHEMBL17555109 0.81 PYGL (0.55) PYGLNHERF1MEN1KMT2ARXFP1
Iodide SCHEMBL3081990 0.81 PYGL (0.61) PYGLNHERF1MEN1KMT2ARXFP1
SCHEMBL13148361 0.80 CCR2 (0.69) PYGLNHERF1MEN1KMT2ARXFP1
SCHEMBL13148369 0.80 PYGL (0.56) PYGLNHERF1MEN1KMT2ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765803-B1 QUATERNARY SALT CCR2 ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2016-03-09 EP disclosed